Literature DB >> 10330337

Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein.

J R Riordan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330337      PMCID: PMC1377893          DOI: 10.1086/302429

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  38 in total

1.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.

Authors:  S H Cheng; R J Gregory; J Marshall; S Paul; D W Souza; G A White; C R O'Riordan; A E Smith
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

2.  Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome.

Authors:  M A Loo; T J Jensen; L Cui; Y Hou; X B Chang; J R Riordan
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

3.  Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes.

Authors:  M L Drumm; D J Wilkinson; L S Smit; R T Worrell; T V Strong; R A Frizzell; D C Dawson; F S Collins
Journal:  Science       Date:  1991-12-20       Impact factor: 47.728

4.  Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.

Authors:  G M Denning; M P Anderson; J F Amara; J Marshall; A E Smith; M J Welsh
Journal:  Nature       Date:  1992-08-27       Impact factor: 49.962

5.  The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment.

Authors:  Y Yang; S Janich; J A Cohn; J M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

6.  Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland.

Authors:  N Kartner; O Augustinas; T J Jensen; A L Naismith; J R Riordan
Journal:  Nat Genet       Date:  1992-08       Impact factor: 38.330

7.  The cystic fibrosis transmembrane conductance regulator. Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide.

Authors:  P J Thomas; P Shenbagamurthi; J Sondek; J M Hullihen; P L Pedersen
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

8.  Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator.

Authors:  S Pind; J R Riordan; D B Williams
Journal:  J Biol Chem       Date:  1994-04-29       Impact factor: 5.157

9.  Rapid endocytosis of the cystic fibrosis transmembrane conductance regulator chloride channel.

Authors:  L S Prince; R B Workman; R B Marchase
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

10.  Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins.

Authors:  C L Ward; R R Kopito
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

View more
  34 in total

1.  A novel CFTR disease-associated mutation causes addition of an extra N-linked oligosaccharide.

Authors:  M M Hämmerle; A A Aleksandrov; X B Chang; J R Riordan
Journal:  Glycoconj J       Date:  2000-11       Impact factor: 2.916

Review 2.  From the ER to the golgi: insights from the study of combined factors V and VIII deficiency.

Authors:  W C Nichols; D Ginsburg
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

3.  Comparative genomic sequence analysis of the human and mouse cystic fibrosis transmembrane conductance regulator genes.

Authors:  R E Ellsworth; D C Jamison; J W Touchman; S L Chissoe; V V Braden Maduro; G G Bouffard; N L Dietrich; S M Beckstrom-Sternberg; L M Iyer; L A Weintraub; M Cotton; L Courtney; J Edwards; R Maupin; P Ozersky; T Rohlfing; P Wohldmann; T Miner; K Kemp; J Kramer; I Korf; K Pepin; L Antonacci-Fulton; R S Fulton; P Minx; L W Hillier; R K Wilson; R H Waterston; W Miller; E D Green
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 4.  Protein misfolding, aggregation, and degradation in disease.

Authors:  Niels Gregersen; Lars Bolund; Peter Bross
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

5.  Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures.

Authors:  Deborah M Cholon; Wanda K O'Neal; Scott H Randell; John R Riordan; Martina Gentzsch
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-11       Impact factor: 5.464

Review 6.  Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: progress and prognosis.

Authors:  Susan L Lindquist; Jeffery W Kelly
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-12-01       Impact factor: 10.005

7.  Subcellular localisation, secretion, and post-translational processing of normal cochlin, and of mutants causing the sensorineural deafness and vestibular disorder, DFNA9.

Authors:  N G Robertson; S A Hamaker; V Patriub; J C Aster; C C Morton
Journal:  J Med Genet       Date:  2003-07       Impact factor: 6.318

8.  Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator.

Authors:  Martina Gentzsch; Xiu-Bao Chang; Liying Cui; Yufeng Wu; Victor V Ozols; Amit Choudhury; Richard E Pagano; John R Riordan
Journal:  Mol Biol Cell       Date:  2004-04-09       Impact factor: 4.138

9.  Amyloid formation in human IAPP transgenic mouse islets and pancreas, and human pancreas, is not associated with endoplasmic reticulum stress.

Authors:  R L Hull; S Zraika; J Udayasankar; K Aston-Mourney; S L Subramanian; S E Kahn
Journal:  Diabetologia       Date:  2009-04-08       Impact factor: 10.122

10.  Molecular models of the open and closed states of the whole human CFTR protein.

Authors:  Jean-Paul Mornon; Pierre Lehn; Isabelle Callebaut
Journal:  Cell Mol Life Sci       Date:  2009-08-26       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.